Tagged with GI

COVID-19 Oral Antivirals Expected to Generate USD 32.5 Billion in 2022
MEA Pharma Market to Reach USD 47 billion in 2022; Gilead’s Sales Skyrocketing
After Second Recall of Moderna Vaccines, Spanish Regulator Calls for New Inspection Procedures
Pierluigi Petrone – CEO, Petrone Group & President, ASSORAM
Andrea Lodetti – CEO, Bormioli Pharma
Five Key Trends in MEA Medtech
Maher Abouzeid – Managing Director, MedServe Medical Investment (April 2022)
Stephane Brocker – Country President, Managing Director Italy, Ipsen
Implementing New GVP in China Requires Digitalisation and Training
Clinical Trials in Italy: Four Pharma Country Managers Have Their Say
China Pharma News: Paxlovid Approval; Anti-Monopoly Push; FDA Concern for China Developed Drugs
Are You Smart Enough? Blockchain & Smart Contract Applications in Pharma
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here